Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy: An Open-Label Pilot Study

Author: Nigishi Hotta   Keigo Yasuda  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.24, Iss.11, 2004-01, pp. : 671-680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content